Management of Persistent Pruritus and Lichenoid Reaction Secondary to Nivolumab With Narrowband Ultraviolet B Phototherapy

Management of Persistent Pruritus and Lichenoid Reaction Secondary to Nivolumab With Narrowband Ultraviolet B Phototherapy

Immune checkpoint inhibitors targeting the programmed cell death receptor 1 (PD-1) are increasingly used to treat several malignancies, with the most common adverse event being cutaneous toxicity. We report the case of a 68-years-old man with stage IV non-small cell lung cancer treated with nivoluma...

Full description

Bibliographic Details
Main Authors: Marie Donaldson, Joshua L. Owen, Young K. Chae, Jennifer N. Choi
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-09-01
Series:Frontiers in Oncology
Subjects:
PD-1 inhibitor
nivolumab
lichenoid
dermatitis
immunotherapy
phototherapy
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2018.00405/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2018.00405/full

Similar Items